HealthLinx Releases Data Suggesting Usefulness of Biomarker for Detection of Prostate Cancer

In a study using a well-defined set of 30 prostate cancer plasma samples and 14 male controls, researchers detected the biomarker in three of the 14 control samples and in 27 of the 30 prostate cancer samples.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.